Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kg, Xanthopoulos"'
Publikováno v:
Gene therapy. 5(5)
We have developed a method for generating high-titer retroviral producer cell lines conditionally containing a neomycin resistance gene (neo(r)) based on the Cre/loxP system. For this, a bicistronic retroviral splicing vector carrying the green fluor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8de93965a98887a7eeb5fb273ba87f
https://pubmed.ncbi.nlm.nih.gov/9797874
https://pubmed.ncbi.nlm.nih.gov/9797874
Publikováno v:
Europe PubMed Central
Retroviral vector-mediated gene transfer into human hematopoietic stem cells (HSC) may permit gene therapy of certain genetic diseases. Stimulation of HSC with hematopoietic growth factors (GF) has been shown to increase the level of retroviral trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5137781014c1364cc20e07f6218a62bd
https://pubmed.ncbi.nlm.nih.gov/7523165
https://pubmed.ncbi.nlm.nih.gov/7523165
Publikováno v:
Development (Cambridge, England). 109(2)
C/EBP is a positive-acting transcription factor important for hepatocyte-specific expression present not only in hepatocytes but also a limited number of other cell types in adult mice. By Northern blot analysis and in situ hybridization experiments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20514d847805358fdac6c61e6baa1154
https://pubmed.ncbi.nlm.nih.gov/2401206
https://pubmed.ncbi.nlm.nih.gov/2401206
Publikováno v:
Europe PubMed Central
Bruton's agammaglobulinemia tyrosine kinase (Btk) is a cytoplasmic tyrosine kinase involved in the human disease X-linked agammaglobulinemia (XLA). The gene is expressed in all hematopoietic cells with the exception of T-cells and plasma cells. For t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::546e536824c81f61b6963cde8ef3656d
http://europepmc.org/abstract/med/8934542
http://europepmc.org/abstract/med/8934542
Autor:
HORÁČKOVÁ, šÁRKA1 sarka.horackova@vscht.cz, MÜHLHANSOVÁ, ANDREA1, SLUKOVÁ, MARCELA2, SCHULZOVÁ, VÊRA3, PLOCKOVÁ, MILADA1
Publikováno v:
Czech Journal of Food Sciences. 2015, Vol. 33 Issue 4, p313-319. 7p.
Autor:
Crich, Simonetta Geninatti1, Lanzardo, Stefania1, Barge, Alessandro1, Esposito, Giovanna1, Tei, Lorenzo1, Forni, Guido1, Aime, Silvio1 silvio.aime@unito.it
Publikováno v:
Molecular Imaging. Jan2005, Vol. 4 Issue 1, p7-17. 11p.
Publikováno v:
Gene Therapy. May98, Vol. 5 Issue 5, p684. 8p.
Autor:
Tomizawa, Minoru, Shinozaki, Fuminobu, Motoyoshi, Yasufumi, Sugiyama, Takao, Yamamoto, Shigenori, Ishige, Naoki
Publikováno v:
Journal of Cellular Biochemistry; Sep2016, Vol. 117 Issue 9, p2001-2009, 9p
Autor:
Holtzman SH; Decibel Therapeutics, Inc., Cambridge, MA, USA., Cohen R; Acorda Therapeutics, Inc., Ardsley, NY, USA., Levin JM; Ovid Therapeutics, New York, NY, USA. jlevin@ovidrx.com., Maraganore J; Alnylam Pharmaceuticals, Cambridge, MA, USA.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2019 Nov; Vol. 37 (11), pp. 1261-1263.
Autor:
Meyer, Florencia, Jones, Clinton
Publikováno v:
Journal of NeuroVirology; Apr2009, Vol. 15 Issue 2, p123-130, 8p, 2 Diagrams, 3 Graphs